Group One Trading
RVMD icon

Group One Trading’s Revolution Medicines RVMD Stock Holding History

Group One Trading’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,145
Closed -$4.05M – 8587
2025
Q4 		$3.2M Buy
40,145
+35,865
+838% +$2.35M 0.01% 1857
2025
Q3 		$200K Buy
+4,280
New +$168K ﹤0.01% 4666
2025
Q1 		– Sell
-3,201
Closed -$130K – 8275
2024
Q4 		$140K Sell
3,201
-2,347
-42% -$118K ﹤0.01% 4233
2024
Q3 		$252K Sell
5,548
-293
-5% -$12.8K ﹤0.01% 3418
2024
Q2 		$227K Buy
+5,841
New +$218K ﹤0.01% 3286
2024
Q1 		– Sell
-3,088
Closed -$91.5K – 7844
2023
Q4 		$88.6K Buy
+3,088
New +$74.2K ﹤0.01% 4568
2023
Q2 		– Sell
-238
Closed -$5.84K – 8135
2023
Q1 		$5.16K Buy
+238
New +$5.86K ﹤0.01% 6265
2022
Q4 		– Sell
-21,000
Closed -$414K – 7981
2022
Q3 		$414K Buy
21,000
+200
+1% +$4.39K ﹤0.01% 3415
2022
Q2 		$405K Buy
+20,800
New +$405K ﹤0.01% 3627

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Group One Trading's RVMD Position: Q1 2026 in Review

Group One Trading sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 40,145 shares — an estimated $4.05M sold.

Group One Trading first reported a position in RVMD in Q2 2022 and held it in 9 quarters. The position peaked at $3.2M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Group One Trading reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 40,145 Revolution Medicines shares in Q1 2026, an estimated $4.05M.
  • Group One Trading first reported a position in Revolution Medicines in Q2 2022 and held it in 9 quarters.
  • Group One Trading's Revolution Medicines position peaked at $3.2M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.